BRUNSWICK, Maine, Dec. 11, 2023 /PRNewswire/ — Maridose, a leading DEA licensed manufacturer specializing in cannabis-based products, proudly announces the launch of their groundbreaking Contract Research Organization (CRO) group. This newly formed group is dedicated to collaborating with researchers engaged in the development of cannabis-based drugs for pre-clinical and clinical trials, as well as aiding in the commercialization process. Read more
Maridose Launches Innovative CRO Group for Cannabis-Based Drug Development
Related Posts
Maine’s life sciences sector growth could outpace other industries
Maine’s $2.3 billion life sciences sector, which employed close to 10,000 people in 2024, will outpace the growth of many other...
IDEXX gets wiggle room to buy back more shares
IDEXX Laboratories Inc. (Nasdaq: IDXX), a Westbrook-based maker of veterinary diagnostics and software, has the green light from its board of...
Maine’s first accredited lab for PFAS testing is expanding to meet demand
NORRIDGEWOCK, Maine — This week, the Biden administration moved to prevent dangerous “forever chemicals” from being released onto the market after a less...